Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 12.114 Q1 | 254 | 36 | 91 | 13930 | 2347 | 91 | 20.90 | 386.94 | |
2 | Medicinal Research Reviews | journal | 2.746 Q1 | 150 | 35 | 87 | 7834 | 749 | 85 | 8.31 | 223.83 | |
3 | Issues in Toxicology | book series | 0.160 Q4 | 18 | 40 | 122 | 8309 | 50 | 114 | 0.27 | 207.73 | |
4 | Pharmacology and Therapeutics | journal | 3.622 Q1 | 233 | 105 | 312 | 21154 | 3026 | 311 | 9.21 | 201.47 | |
5 | Reviews of Physiology Biochemistry and Pharmacology | journal | 1.754 Q1 | 70 | 5 | 10 | 931 | 41 | 10 | 4.10 | 186.20 | |
6 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.920 Q2 | 82 | 15 | 34 | 2655 | 135 | 34 | 4.26 | 177.00 | |
7 | Journal of Experimental Pharmacology | journal | 0.129 Q4 | 23 | 1 | 3 | 166 | 2 | 3 | 0.50 | 166.00 | |
8 | Journal of Receptor, Ligand and Channel Research | journal | 0.481 Q3 | 13 | 2 | 12 | 279 | 23 | 11 | 0.43 | 139.50 | |
9 | Current Neuropharmacology | journal | 0.951 Q2 | 103 | 48 | 170 | 6542 | 547 | 161 | 2.60 | 136.29 | |
10 | Advances in Molecular Toxicology | book series | 0.371 Q3 | 18 | 7 | 23 | 939 | 34 | 6 | 1.20 | 134.14 | |
11 | Annual Review of Pharmacology and Toxicology | journal | 10.782 Q1 | 224 | 27 | 61 | 3273 | 1517 | 61 | 21.39 | 121.22 | |
12 | Cellular and Molecular Life Sciences | journal | 3.339 Q1 | 261 | 301 | 893 | 36153 | 5840 | 887 | 6.40 | 120.11 | |
13 | Drug Resistance Updates | journal | 3.734 Q1 | 132 | 10 | 72 | 1170 | 828 | 67 | 10.58 | 117.00 | |
14 | Current Medicinal Chemistry | journal | 1.373 Q1 | 202 | 359 | 1223 | 41513 | 5433 | 1164 | 4.02 | 115.64 | |
15 | Current Vascular Pharmacology | journal | 0.783 Q2 | 69 | 94 | 268 | 10596 | 775 | 248 | 2.82 | 112.72 | |
16 | Current Pharmaceutical Design | journal | 1.295 Q1 | 183 | 659 | 1399 | 71581 | 5281 | 1284 | 3.55 | 108.62 | |
17 | Current Cancer Drug Targets | journal | 1.585 Q1 | 103 | 82 | 269 | 8657 | 1036 | 249 | 3.79 | 105.57 | |
18 | Current Drug Metabolism | journal | 1.138 Q1 | 122 | 100 | 302 | 10414 | 1284 | 266 | 3.59 | 104.14 | |
19 | Journal of Applied Research | journal | 0.148 Q4 | 23 | 2 | 40 | 203 | 14 | 39 | 0.17 | 101.50 | |
20 | Vaccines | journal | 85 | 2 | 0 | 202 | 0 | 0 | 0.00 | 101.00 | ||
21 | Advances in Pharmacology | journal | 2.633 Q1 | 86 | 40 | 106 | 3814 | 517 | 1 | 5.30 | 95.35 | |
22 | Current Molecular Pharmacology | journal | 1.455 Q1 | 49 | 20 | 71 | 1907 | 251 | 65 | 2.88 | 95.35 | |
23 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.199 Q3 | 29 | 12 | 34 | 1144 | 19 | 0 | 0.58 | 95.33 | |
24 | Expert Opinion on Emerging Drugs | journal | 0.951 Q2 | 54 | 40 | 136 | 3787 | 434 | 134 | 3.44 | 94.68 | |
25 | Neurotherapeutics | journal | 2.471 Q1 | 136 | 71 | 188 | 6671 | 1188 | 174 | 4.48 | 93.96 | |
26 | Progress in Medicinal Chemistry | journal | 0.983 Q2 | 38 | 6 | 17 | 543 | 50 | 1 | 3.55 | 90.50 | |
27 | Expert Opinion on Therapeutic Targets | journal | 2.023 Q1 | 106 | 130 | 359 | 11733 | 1726 | 355 | 4.86 | 90.25 | |
28 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.495 Q3 | 45 | 26 | 75 | 2332 | 108 | 69 | 1.10 | 89.69 | |
29 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q2 | 107 | 164 | 355 | 14556 | 1230 | 337 | 3.42 | 88.76 | |
30 | Expert Opinion on Therapeutic Patents | journal | 1.188 Q1 | 88 | 112 | 330 | 9802 | 1165 | 324 | 3.50 | 87.52 | |
31 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 128 | 368 | 11082 | 1279 | 366 | 3.49 | 86.58 | |
32 | Current Drug Targets | journal | 1.548 Q1 | 119 | 174 | 546 | 14997 | 2193 | 496 | 3.67 | 86.19 | |
33 | Clinical Medicine Insights: Therapeutics | journal | 0.117 Q4 | 11 | 13 | 105 | 1049 | 31 | 105 | 0.32 | 80.69 | |
34 | Expert Opinion on Investigational Drugs | journal | 1.489 Q1 | 117 | 139 | 452 | 10890 | 1969 | 440 | 4.39 | 78.35 | |
35 | Current Topics in Pharmacology | journal | 0.109 Q4 | 8 | 16 | 35 | 1240 | 2 | 35 | 0.00 | 77.50 | |
36 | Journal of NeuroImmune Pharmacology | journal | 1.264 Q1 | 91 | 109 | 212 | 8448 | 726 | 201 | 2.79 | 77.50 | |
37 | Infectious Disorders - Drug Targets | journal | 0.707 Q2 | 61 | 38 | 139 | 2911 | 264 | 125 | 1.68 | 76.61 | |
38 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.122 Q1 | 108 | 174 | 321 | 13259 | 994 | 287 | 2.85 | 76.20 | |
39 | Therapeutic Advances in Neurological Disorders | journal | 1.144 Q1 | 68 | 31 | 88 | 2319 | 397 | 86 | 4.82 | 74.81 | |
40 | CNS and Neurological Disorders - Drug Targets | journal | 1.287 Q1 | 96 | 140 | 308 | 10449 | 972 | 269 | 2.61 | 74.64 | |
41 | Molecular Diagnosis and Therapy | journal | 0.759 Q2 | 68 | 36 | 112 | 2679 | 256 | 105 | 2.41 | 74.42 | |
42 | Expert Opinion on Biological Therapy | journal | 1.288 Q1 | 102 | 163 | 471 | 12106 | 1906 | 462 | 3.98 | 74.27 | |
43 | Altex | journal | 0.841 Q2 | 64 | 39 | 102 | 2875 | 293 | 81 | 2.78 | 73.72 | |
44 | Frontiers in Pharmacology | journal | 1.352 Q1 | 154 | 150 | 335 | 11057 | 1197 | 329 | 3.70 | 73.71 | |
45 | BioDrugs | journal | 0.871 Q2 | 79 | 56 | 137 | 4080 | 452 | 134 | 2.69 | 72.86 | |
46 | Pharmacognosy Reviews (discontinued) | journal | 0.862 Q2 | 68 | 25 | 73 | 1805 | 281 | 72 | 3.45 | 72.20 | |
47 | Pharmacological Research | journal | 1.702 Q1 | 169 | 128 | 433 | 9193 | 2275 | 421 | 4.58 | 71.82 | |
48 | Neuropharmacology | journal | 2.428 Q1 | 191 | 435 | 956 | 31006 | 4802 | 939 | 5.11 | 71.28 | |
49 | Expert Review of Vaccines | journal | 1.381 Q1 | 105 | 142 | 459 | 10084 | 1679 | 380 | 3.54 | 71.01 | |
50 | Clinical Pharmacokinetics | journal | 2.140 Q1 | 184 | 78 | 175 | 5515 | 1295 | 165 | 6.14 | 70.71 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®